Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study

MLA

Gilbert Bensimon, et al. “Stage at Which Riluzole Treatment Prolongs Survival in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Analysis of Data from a Dose-Ranging Study.” The Lancet Neurology, Jan. 2018. EBSCOhost, https://doi.org/10.1016/S1474-4422(18)30054-1.

APA

Gilbert Bensimon, Ammar Al-Chalabi, Ashley R. Jones, Ton Fang, Ahmad Al Khleifat, Jacques-Henri Meurgey, & P. Nigel Leigh. (2018). Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. The Lancet Neurology. https://doi.org/10.1016/S1474-4422(18)30054-1

Chicago

Gilbert Bensimon, Ammar Al-Chalabi, Ashley R. Jones, Ton Fang, Ahmad Al Khleifat, Jacques-Henri Meurgey, and P. Nigel Leigh. 2018. “Stage at Which Riluzole Treatment Prolongs Survival in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Analysis of Data from a Dose-Ranging Study.” The Lancet Neurology, January. doi:10.1016/S1474-4422(18)30054-1.